Published by Josh White on 9th February 2021
(Sharecast News) - Specialist drug discovery and development company ImmuPharma updated the market on the new optimised international phase 3 trial of 'Lupuzor' in the potentially life-threatening auto-immune disease systemic lupus erythematosus (SLE) on Tuesday.
URL: http://www.digitallook.com/dl/news/story/31634179/...